Spyre Therapeutics (SYRE) Announces Positive Results for Phase 1 Study of SPY003
Spyre Therapeutics, Inc. (NASDAQ:SYRE) is one of the Hottest Small Cap Stocks to Buy Now. On November 4, Spyre Therapeutics, ...
Wednesday, April 22, 2026
Tag: SPY003
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.